AMAZE™ Asthma Implementation QI Study

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Asthma
Interventions
DEVICE

AMAZE™ Disease Management Platform

The disease management platform includes a patient mobile application where patients can enter daily symptoms, communicate with their healthcare providers, and access educational materials. Additionally, the healthcare providers will have access to a dashboard that is integrated with the EMR and patient app.

Trial Locations (2)

78730

Research Site, Austin

78746

Research Site, Austin

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Greater Austin Allergy

UNKNOWN

collaborator

Evidera, Inc.

UNKNOWN

lead

AstraZeneca

INDUSTRY